Mark Brantly
Impact in
- Cancer Research top 0.5%
- Protease and Inhibitor Mechanisms
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Protease and Inhibitor Mechanisms 79
- Oncology 35
- Peptidase Inhibition and Analysis 33
- Co-authors
- Ronald G. Crystal (25 shared papers)Toshihiro Nukiwa (4 shared papers)James K. Stoller (17 shared papers)Farshid N. Rouhani (21 shared papers)Terence R. Flotte (7 shared papers)Mark Holmes (9 shared papers)Charlie Strange (20 shared papers)Michael Courtney (9 shared papers)
- Journals
- CHEST Journal (11 papers)COPD Journal of Chronic Obstructive Pulmonary Disease (9 papers)PLoS ONE (9 papers)Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation (9 papers)Journal of Biological Chemistry (6 papers)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Mark Brantly
185 papers receiving 10.6k citations
Mark Brantly's Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 3.6k
- Hematology 1.2k
- Oncology 2.6k
- Pulmonary and Respiratory Medicine 2.2k
- Physiology 1.6k
Countries citing papers authored by Mark Brantly
This map shows the geographic impact of Mark Brantly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Brantly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Brantly more than expected).
Fields of papers citing papers by Mark Brantly
This network shows the impact of papers produced by Mark Brantly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Brantly. The network helps show where Mark Brantly may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Brantly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis Hit paper breakdown → | 2011 | 850 |
| 2 | 1996 | 479 | |
| 3 | 1988 | 434 | |
| 4 | 2005 | 422 | |
| 5 | 2011 | 288 | |
| 6 | 2009 | 286 | |
| 7 | 2016 | 261 | |
| 8 | 1998 | 260 | |
| 9 | 1988 | 253 | |
| 10 | 1998 | 247 | |
| 11 | 1988 | 198 | |
| 12 | 1997 | 189 | |
| 13 | 1989 | 188 | |
| 14 | 2016 | 163 | |
| 15 | 2013 | 160 | |
| 16 | 2002 | 160 | |
| 17 | Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. | 1989 | 155 |
| 18 | 1991 | 155 | |
| 19 | 2006 | 154 | |
| 20 | 1996 | 147 |
About Mark Brantly
Mark Brantly is a scholar working on Cancer Research, Oncology, Hematology, Molecular Biology and Cell Biology, having authored 189 papers that have together received 11.1k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (79 papers), Peptidase Inhibition and Analysis (33 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers), Virus-based gene therapy research (15 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers), Pulmonary Hypertension Research and Treatments (10 papers), RNA and protein synthesis mechanisms (10 papers) and Endoplasmic Reticulum Stress and Disease (9 papers). The work is most often cited by research in Cancer Research (3.6k citations), Hematology (1.2k citations), Oncology (2.6k citations), Pulmonary and Respiratory Medicine (2.2k citations) and Physiology (1.6k citations). Mark Brantly has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Ronald G. Crystal, Toshihiro Nukiwa, James K. Stoller, Farshid N. Rouhani, Terence R. Flotte, Mark Holmes, Charlie Strange, Michael Courtney, David T. Curiel and Noel Gerard McElvaney. Their work appears in journals such as CHEST Journal, COPD Journal of Chronic Obstructive Pulmonary Disease, PLoS ONE, Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.